Michael Fahey

Professor Michael Fahey is a leading academic and clinician in paediatric neurology and neurogenetics at Monash University, affiliated with the School of Clinical Sciences at Monash Health and based at Monash Medical Centre. He serves as Head of the Paediatric Neurology Unit and is actively involved in clinical care, research, and training.

• University: Monash University
• School: School of Clinical Sciences at Monash Health
• Department: Paediatrics
• Academic Rank: Professor

His research is centered on neurogenetics, with a focus on understanding the genetic causes of cerebral palsy, developmental and epileptic encephalopathies, movement disorders, and rare neurometabolic diseases. He aims to transition from disease management to curative therapies through genetic insights.

His recent publications and ongoing clinical trials highlight a strong trend in translational neuroscience, particularly in gene discovery, pharmacological interventions (e.g., valbenazine, LP352), and novel therapies like mitochondrial donation and medicinal cannabis. His work bridges molecular genetics with clinical neurology, emphasizing early diagnosis and targeted treatments.

• Fulbright Scholarship (2018)

Professor Fahey leads multiple research grants and clinical trials, including a Phase 3 study on valbenazine for dyskinesia in cerebral palsy and the MitoHOPE program on mitochondrial donation. He collaborates extensively with institutions such as the Ritchie Centre, Murdoch Children’s Research Institute, Alfred Hospital, and Royal Melbourne Hospital. He supervises research in neurology, neurogenetics, and cerebral palsy, though specific student names are not listed.

He co-founded a mitochondrial clinic and is integral to neurogenetics clinics at Royal Melbourne and St Vincents Hospitals. His work is supported by a robust network of clinical and research teams focused on improving outcomes for children with neurological and genetic disorders.